A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure-Reference-Cited by-同舟云学术

A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure

Published:2016-12 Issue:7 Volume:1 Page:576-586
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Lenihan Daniel J.,Anderson Sarah A.,Lenneman Carrie Geisberg,Brittain Evan,Muldowney James A.S.,Mendes Lisa,Zhao Ping Z.,Iaci Jennifer,Frohwein Stephen,Zolty Ronald,Eisen Andrew,Sawyer Douglas B.,Caggiano Anthony O.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Heart failure;Braunwald;J Am Coll Cardiol HF,2013

2. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993–2010: findings from a university referral center;Loh;Circ Heart Fail,2013

3. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras;Cubbon;Circ Heart Fail,2011

4. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

5. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J Am Coll Cardiol,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of NRG1-VII: the myeloid-derived class of NRG1;BMC Genomics;2024-08-29

2. Effects and mechanisms of the myocardial microenvironment on cardiomyocyte proliferation and regeneration;Frontiers in Cell and Developmental Biology;2024-07-10

3. Molecular insights of exercise therapy in disease prevention and treatment;Signal Transduction and Targeted Therapy;2024-05-29

4. Small molecule-induced ERBB4 activation to treat heart failure;2024-04-08

5. The case for neuregulin-1 as a clinical treatment for stroke;Frontiers in Cellular Neuroscience;2024-04-04